Literature DB >> 20130868

Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma.

Tracy-Ann Moo1, Julie McGill, John Allendorf, James Lee, Thomas Fahey, Rasa Zarnegar.   

Abstract

BACKGROUND: Although the role of prophylactic central neck lymph node dissection (CNLD) in the treatment of papillary thyroid carcinoma (PTC) is controversial, many surgeons perform routine prophylactic CNLD. The present study compares local recurrence rates in PTC patients undergoing total thyroidectomy with and without prophylactic CNLD.
MATERIALS AND METHODS: A retrospective review of 206 patients undergoing thyroidectomy for PTC was conducted at two tertiary referral centers. Of these, 81 patients had total thyroidectomy for PTC and a follow-up between 2 and 9 years with a mean of 3.1 years. Of these 81 patients, 45 underwent routine prophylactic CNLD and 36 did not. For those two groups, demographics, clinical and pathologic findings, radioactive iodine (RAI) treatment, and the incidence of recurrence were compared. Univariate statistical analysis was performed.
RESULTS: There was no significant difference in age, gender, multifocality, or extrathyroidal extension for the two groups. Patients with CNLD had an average tumor size of 1.4 cm versus 2 cm in the group without CNLD (p < 0.05). Patients who underwent CNLD had an average of 8 nodes removed, and positive nodes were found in 33%. Patients with CNLD received a higher dose of RAI, 102.7 mCi versus 66.3 mCi (p < 0.05). The incidence of positive nodes correlated with an increased RAI dose (r = 0.55). Rates of parathyroid removal and autotransplantation were higher in the CNLD group, 36 and 16% in the CNLD group versus 22 and 3% in the group without CNLD (p = 0.4 and p = 0.07). Rates of temporary hypocalcemia were higher in the CNLD group (31 versus 5%; p = 0.001), however rates of permanent hypocalcemia were similar, 1/35 in the no CNLD group versus 0/45 in the CNLD group (p = 0.4). There was a higher recurrence rate among patients without CNLD 6/36 (16.7%) versus 2/45 (4.4%), although this difference was not statistically significant (p = 0.13).
CONCLUSIONS: Routine CNLD as an adjunct to total thyroidectomy identifies positive nodes in over 30% of patients with PTC. The discovery of positive nodes is associated with higher doses of RAI for postoperative ablation, and there is a trend toward decreased recurrence in patients undergoing CNLD.

Entities:  

Mesh:

Year:  2010        PMID: 20130868     DOI: 10.1007/s00268-010-0418-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; C S Grant; B McIver; G B Thompson; J A van Heerden; J R Goellner
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

2.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

3.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

Review 4.  Surgery of lymph nodes in papillary thyroid cancer.

Authors:  Gianlorenzo Dionigi; Renzo Dionigi; Luigi Bartalena; Luigi Boni; Francesca Rovera; Francesca Villa
Journal:  Expert Rev Anticancer Ther       Date:  2006-09       Impact factor: 4.512

5.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

6.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

7.  Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience.

Authors:  N Palestini; A Borasi; L Cestino; M Freddi; C Odasso; A Robecchi
Journal:  Langenbecks Arch Surg       Date:  2008-07-01       Impact factor: 3.445

8.  Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer.

Authors:  G F Scheumann; O Gimm; G Wegener; H Hundeshagen; H Dralle
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

Review 9.  An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer.

Authors:  Anna M Sawka; James D Brierley; Richard W Tsang; Lehana Thabane; Lorne Rotstein; Amiram Gafni; Sharon Straus; David P Goldstein
Journal:  Endocrinol Metab Clin North Am       Date:  2008-06       Impact factor: 4.741

10.  Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.

Authors:  Stéphane Bonnet; Dana Hartl; Sophie Leboulleux; Eric Baudin; Jean D Lumbroso; Abir Al Ghuzlan; Linda Chami; Martin Schlumberger; Jean Paul Travagli
Journal:  J Clin Endocrinol Metab       Date:  2008-12-30       Impact factor: 5.958

View more
  56 in total

1.  Quantification of lymph nodes in the central compartment of the neck: a cadaveric study.

Authors:  Enyinnaya Ofo; Selvam Thavaraj; Daron Cope; James Barr; Karan Kapoor; Jean-Pierre Jeannon; Richard Oakley; Claire Lock; Edward Odell; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-20       Impact factor: 2.503

2.  Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China.

Authors:  Yingying Xiang; Kuailu Lin; Siyang Dong; L I Qiao; Qiuxiang He; Xiaohua Zhang
Journal:  Oncol Lett       Date:  2015-07-29       Impact factor: 2.967

3.  Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.

Authors:  Amanda M Laird; Paul G Gauger; Barbra S Miller; Gerard M Doherty
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 4.  Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Juan J Sancho; Thomas W Jay Lennard; Ivan Paunovic; Frédéric Triponez; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2013-12-19       Impact factor: 3.445

Review 5.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

6.  Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: a systematic review.

Authors:  Torben Harsløf; Lars Rolighed; Lars Rejnmark
Journal:  Endocrine       Date:  2019-02-20       Impact factor: 3.633

7.  Correlation analysis on central lymph node metastasis in 276 patients with cN0 papillary thyroid carcinoma.

Authors:  Wendong Wang; Jialei Gu; Jinbiao Shang; Kejing Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

Review 8.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

9.  Prognostic Value of the Number of Retrieved Lymph Nodes in Pathological Nx or N0 Classical Papillary Thyroid Carcinoma.

Authors:  Tae-Yon Sung; Jong Ho Yoon; Dong Eun Song; Yu-Mi Lee; Tae-Yong Kim; Ki-Wook Chung; Won Bae Kim; Young Kee Shong; Suck Joon Hong
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

10.  Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma.

Authors:  Dana M Hartl; Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Martin Schlumberger
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.